Abstract:
The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents.
Abstract:
Compounds are described that are effective in enhancing the efficacy of antimicrobial agents. Also described are methods of using such compounds and compositions that include such compounds. The composition includes a chalcone compound and, optionally, an antimicrobial agent.
Abstract:
In one embodiment of the invention, a method of analysis of a circuit design is disclosed to generate a statistical timing model. The method includes receiving a timing graph of a circuit including arcs with a statistical function of delay, slew, or arrival time; determining primary input ports and output ports of the circuit; identifying timing pins between the input ports and the output ports of the circuit; and evaluating the timing pins from input ports to output ports to reduce the timing graph to ease analysis of the reduced timing graph with a processor.
Abstract:
A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty. Once it is determined that the second application server now is the coordinator of the group, a connection is established to the billing system, via the terminal server, by the second application server.
Abstract:
The present invention relates to a process for preparing a carbapenem antibiotic composition. The present invention further relates to a carbapenem antibiotic composition substantially free of degradation impurities. The present invention further relates to a polymorphic form of ertapenem mono sodium designated as Form D and its preparation.
Abstract:
Methods for the hydrogenation of isoflavones are described which provide access to workable quantities of isoflavan-4-ols, isoflav-3-enes, and isoflavans. The isoflavone derivatives can be obtained in high purity and in near quantitative yields whilst employing pharmaceutically acceptable reagents and solvents.
Abstract:
An apparatus and method are provided for analyzing traffic on a network by monitoring packets sent between devices on the network and identifying applications occurring between devices on the network based on information derived from monitoring the packets. Techniques are provided to examine header information of the packets, such as information in the header of Internet Protocol (IP) packets, to identify applications that are occurring on the network. In some cases, information about the packet beyond the header information is examined to match a packet to a particular application. Using these techniques, a list is built of all of the applications occurring between devices on the network. Parameters may be generated to track one or more of the response time, latency and traffic volume associated with a particular device on the network.
Abstract:
The present invention relates to a synergistic herbal composition for lowering the intra ocular pressure in different types of glaucoma and process for the preparation of the same in pharmaceutically acceptable dosage forms.
Abstract:
A method for performing a bias temperature instability test on a device includes performing a first stress on the device. After the first stress, a first measurement is performed to determine a first parameter of the device. After the first measurement, a second stress is performed on the device, wherein only the first parameter is measured between the first stress and the second stress. The method further includes performing a second measurement to determine a second parameter of the device after the second stress. The second parameter is different from the first parameter.
Abstract:
Provided herein are acid addition salts of muscarinic receptor antagonists. Such acid addition salts are muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided herein are processes for the preparation of acid addition salts, pharmaceutical compositions thereof, and methods of treating diseases mediated through muscarinic receptors.